Pneumology - Original Articles Open access

Proportion and number of chronic obstructive pulmonary disease cases attributable to potentially modifiable risk factors in Morocco

Authors

  • Hajar Mahfoudi – articles in this journal Corresponding author Email Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Nassiba Bahra – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Fatima Zahraebartal – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Ibtissam el Harch – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Soumaya Benmaamar – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Moncef Maiouak – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Nabil Tachfouti – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
  • Karima El Rhazi – articles in this journal Department of Epidemiology, Clinical Research and Community Health, Faculty of Medicine, Pharmacy and Dentistry, Sidi Mohamed Ben Abdellah University, Fez; Laboratory of Epidemiology and Research in Health Sciences, Sidi Mohamed Ben Abdellah University, Fez; Hassan II University Hospital Center, Fez, Morocco.
Published
17 September 2025
Issue
Early Access
Section
Pneumology - Original Articles

Abstract

Chronic obstructive pulmonary disease (COPD) is a major global health issue, especially in low- and middle-income countries, with significant mortality and economic impact. The study focuses on estimating the population attributable fraction (PAF) for modifiable risk factors, including smoking, secondhand smoke, occupational dust exposure, underweight, and tuberculosis history. The study aims to provide a rigorous assessment of these factors' contributions to COPD onset. Using national prevalence data and relative risk estimates from high-quality studies, the study calculated the PAF for modifiable COPD risk factors, including smoking and occupational dust exposure, applying Levin’s and Smoking-Attributable Mortality, Morbidity, and Economic Costs formulas. Confidence intervals were determined through the simulated Wald interval method. In Morocco, the PAF for tobacco-related COPD was 47% for men and 5% for women, with over 1.2 million preventable cases in men and about 54,000 cases in women. The PAF for second-hand smoke at home was estimated at 4% in men and 5% in women. In the workplace, this fraction was higher in men (7%) than in women (4%). Occupational exposure to dust accounts for 13% of COPD cases in men and 12% in women, totaling 335,000 and 142,000 avoidable cases, respectively. Underweight contributes to 5% of cases in men and 2% in women, while tuberculosis accounts for over 1% of cases in both genders. COPD is largely influenced by modifiable risk factors like smoking and occupational exposure to dust. By targeting these risk factors, policymakers can significantly reduce future COPD cases.

Ethics Approval

As this study is based solely on the analysis of data from existing literature and does not involve human participants, formal ethical approval was not required.

References

  1. WHO. Bronchopneumopathie chronique obstructive (BPCO). 2024. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  2. WHO. Chronic obstructive pulmonary disease (COPD). 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
  3. Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis. J Glob Health 2015;5:020415. DOI: https://doi.org/10.7189/jogh.05.020415
  4. El Rhazi K, Nejjari C, BenJelloun MC, et al. Prevalence of chronic obstructive pulmonary disease in Fez, Morocco: results from the BOLD study. Int J Tuberc Lung Dis 2016;20:136-41. DOI: https://doi.org/10.5588/ijtld.15.0029
  5. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013;5:235‑45. DOI: https://doi.org/10.2147/CEOR.S34321
  6. Wacker ME, Jörres RA, Karch A, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med 2016;16:70. DOI: https://doi.org/10.1186/s12890-016-0238-9
  7. Laurendeau C, Chouaid C, Roche N. Prise en charge et coûts de la bronchopneumopathie chronique obstructive en France en 2011. Available from: https://www.em-consulte.com/article/1001241/prise-en-charge-et-couts-de-la-bronchopneumopathie. [Article in French].
  8. Benmaamar S, Es-Sabbahi B, Taghyioullah Haiba M, et al. Economic burden of chronic obstructive pulmonary disease in Morocco: a cost of illness study. Monaldi Arch Chest Dis 2025;95:2745. DOI: https://doi.org/10.4081/monaldi.2024.2745
  9. Townend J, Minelli C, Mortimer K, et al. The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study. Eur Respir J 2017;49:1601880. DOI: https://doi.org/10.1183/13993003.01880-2016
  10. Adeloye D, Song P, Zhu Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med 2022;10:447‑58. DOI: https://doi.org/10.1016/S2213-2600(21)00511-7
  11. Holtjer JCS, Bloemsma LD, Beijers RJHCG, et al. Identifying risk factors for COPD and adult-onset asthma: an umbrella review. Eur Respir Rev 2023;32:230009. DOI: https://doi.org/10.1183/16000617.0009-2023
  12. Burney P, Patel J, Minelli C, et al. Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study. Am J Respir Crit Care Med 2021;203:1353-65. DOI: https://doi.org/10.1164/rccm.202005-1990OC
  13. Miettinen OS. Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 1974;99:325‑32. DOI: https://doi.org/10.1093/oxfordjournals.aje.a121617
  14. Schriger DL. Diagnostic testing and the estimation of disease likelihood: replacing sensitivity, specificity, and predictive values with likelihood ratios. Ann Emerg Med 2008;52:480. DOI: https://doi.org/10.1016/j.annemergmed.2008.06.461
  15. Bray F, Soerjomataram I. Population attributable fractions continue to unmask the power of prevention. Br J Cancer 2018;118:1031‑2. DOI: https://doi.org/10.1038/s41416-018-0062-5
  16. Balmes J, Becklake M, Blanc P, et al. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003;167:787‑97. DOI: https://doi.org/10.1164/rccm.167.5.787
  17. Siddharthan T, Grigsby MR, Goodman D, et al. Association between household air pollution exposure and chronic obstructive pulmonary disease outcomes in 13 low- and middle-income country settings. Am J Respir Crit Care Med 2018;197:611‑20. DOI: https://doi.org/10.1164/rccm.201709-1861OC
  18. Eisner MD, Anthonisen N, Coultas D, et al. An Official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;182:693‑718. DOI: https://doi.org/10.1164/rccm.200811-1757ST
  19. Murray JF. The International Union Against Tuberculosis and Lung Disease: its contribution to world lung health. Am J Respir Crit Care Med 1995;151:1697-9. DOI: https://doi.org/10.1164/ajrccm.151.6.7767509
  20. Chen P, Li Y, Wu D, et al. Secondhand smoke exposure and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2023;18:1067‑76. DOI: https://doi.org/10.2147/COPD.S403158
  21. WHO. Second-hand smoke impacts health. Available from: http://www.emro.who.int/tfi/quit-now/secondhand-smoke-impacts-health.html
  22. WHO. Tobacco. Available from: https://www.who.int/news-room/fact-sheets/detail/tobacco
  23. Peng C, Yan Y, Li Z, et al. Chronic obstructive pulmonary disease caused by inhalation of dust. Medicine 2020;99:e21908. DOI: https://doi.org/10.1097/MD.0000000000021908
  24. Atassi M, Kava ACF, Nejjari C, et al. Association between chronic airflow obstruction and socio-economic position in Morocco: BOLD results. Int J Tuberc Lung Dis 2020;24:202‑6. DOI: https://doi.org/10.5588/ijtld.19.0170
  25. WHO. Tuberculose. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/tuberculosis
  26. Byrne AL, Marais BJ, Mitnick CD, et al. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis 2015;32:138‑46. DOI: https://doi.org/10.1016/j.ijid.2014.12.016
  27. Ministry of Health, Morocco. National Survey on Common Risk Factors of Noncommunicable Diseases (STEPS). Available from: https://www.sante.gov.ma/Documents/2019/05/Rapport%20de%20l%20enqu%C3%AAte%20Stepwise.pdf
  28. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum 1953;9:531‑41.
  29. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001;55:508‑14. DOI: https://doi.org/10.1136/jech.55.7.508
  30. Centers for Disease Control and Prevention (CDC). Health NC for CDP and HP (US) O on S and. Smoking-Attributable Morbidity, Mortality, and Economic Costs. In: The health consequences of smoking—50 years of progress: a report of the surgeon general. Atlanta, GA, USA: Centers for Disease Control and Prevention (US); 2014.
  31. Greenland S. Interval estimation by simulation as an alternative to and extension of confidence intervals. Int J Epidemiol 2004;33:1389‑97. DOI: https://doi.org/10.1093/ije/dyh276
  32. Nejjari C, Benjelloun MC, Berraho M, et al. Prevalence and demographic factors of smoking in Morocco. Int J Public Health 2009;54:447‑51. DOI: https://doi.org/10.1007/s00038-009-0082-2
  33. Buist AS, Vollmer WM, Sullivan SD, et al. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD 2005;2:277‑83. DOI: https://doi.org/10.1081/COPD-200057610
  34. Forey BA, Thornton AJ, Lee PN. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011;11:36. DOI: https://doi.org/10.1186/1471-2466-11-36
  35. Lee PN, Forey BA, Coombs KJ, et al. Epidemiological evidence relating environmental smoke to COPD in lifelong non-smokers: a systematic review. F1000Res 2018;7:146. DOI: https://doi.org/10.12688/f1000research.13887.1
  36. WHO. Tabac. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/tobacco.
  37. Bafunno D, Catino A, Lamorgese V, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Thorac Dis 2020;12:3844-56. DOI: https://doi.org/10.21037/jtd.2020.02.23
  38. U.S. Department of Health and Human Services. Smoking cessation: a report of the surgeon general. Washington, DC: U.S. Government Printing Office; 2020.
  39. Blanc PD, Annesi-Maesano I, Balmes JR, et al. The occupational burden of nonmalignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement. Am J Respir Crit Care Med 2019;199:1312. DOI: https://doi.org/10.1164/rccm.201904-0717ST
  40. Grahn K, Gustavsson P, Andersson T, et al. Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD): a population-based cohort study in Stockholm, Sweden. Environ Res 2021;200:111739. DOI: https://doi.org/10.1016/j.envres.2021.111739
  41. GBD 2016 Occupational Chronic Respiratory Risk Factors Collaborators, GBD 2016 occupational chronic respiratory risk factors collaborators. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016. Occup Environ Med 2020;77:142‑50. DOI: https://doi.org/10.1136/oemed-2019-106013
  42. Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002;156:738‑46. DOI: https://doi.org/10.1093/aje/kwf105
  43. Rous JS, Lees PSJ, Koehler K, et al. Association of occupational exposures and chronic obstructive pulmonary disease morbidity. J Occup Environ Med 2023;65:e443-52. DOI: https://doi.org/10.1097/JOM.0000000000002850
  44. Wagner GR. Exposition des travailleurs aux poussières minérales: dépistage et surveillance. Available from: https://iris.who.int/bitstream/handle/10665/42054/9242544981.pdf. [Text in French].
  45. Murgia N, Gambelunghe A. Occupational COPD—the most under‐recognized occupational lung disease? Respirology 2022;27:399‑410. DOI: https://doi.org/10.1111/resp.14272
  46. Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD 2015;12:14‑8. DOI: https://doi.org/10.3109/15412555.2014.915934
  47. WHO. Morocco. Célébration de la Journée internationale de lutte contre la tuberculose au Maroc. Available from: http://www.emro.who.int/fr/mor/morocco-events/celebration-de-la-journee-internationale-de-lutte-contre-la-tuberculose-au-maroc.html. [Text in French]
  48. Lee CH, Lee MC, Lin HH, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One 2012;7:e37978. DOI: https://doi.org/10.1371/journal.pone.0037978

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.